Clinical and Experimental Immunology 1997: Vol 109 Index

9 Pages·1997·1.9 MB·English

Author index
ABE, T. see TAKEUCHI, T BRUGNONI, D., Atro, P., TIMPANO, S., MALACARNE, F., UGazio, A.G..
Appessi, M.A. see AFELTRA, A. CATTANEO, R. & Duse, M. CD8* CD28 T cells in vertically HIV
AFELTRA, A., Caccavo, D., Ferri, G.M., Appessi, M.A., De Rosa, infected children, 412
F.G., AMoroso, A. & BONoMo, L. Expression of lactoferrin on human BRUUN, J.A. see DotH, M.
granulocytes: analysis with polyclonal and monoclonal antibodies, 279 BUEHRING, I., FRIEDRICH, B., SCHAAF, J., SCHMIDT, H., AHRENS, P. &
AHRENS, P. see BUEHRING, I ZIELEN, S. Chronic sinusitis refractory to standard management in
ArRO, P. see BRUGNONI, D patients with humoral immunodeficiencies, 468
AruTI, F. see CARL EsIMOo, M BUONCOMPAGNI, A. see GATTORNO, M
AJJAN, R. see PAPPA, A.
AKAKI, T. see TOMIOKA, H. "ACCAVO, D. see AFELTRA, A.
ALEXEYEV, O.A., LINDERHOLM, M., ELGH, F., WADELL, P., Juro, P. & "AL, Y., Krragima, S., Erou, F., Kinosuira, S., OkuBO, K. & HAmMa-
TARNVIK, A. Increased plasma levels of soluble CD23 in haemorrhagic SAKI, N. Autoantibody reactive with the human general transcription
fever with renal syndrome; relation to virus-specific IgE, 351 factor TFIIF in sera from patients with autoimmune disorders, 488
ALTMANN, D.M. see E.Luiott, J.1 ‘ALDER, V. see Pappa, A
AMANO, K. see TAKEUCHI, T. "ARLESIMO, M., PONTESILLI, O., VARANI, A.R., BERNARDI, M.L., Maz-
AMOROSO, A. see AFELTRA, A. ZONE, A.M., Rosso, R., GUERRA, E.C., CASSONE, A., PAGANELLI, R
ANDERSEN, V. see JUUL, L & Aiuti, F. CD28 costimulation and T lymphocyte proliferative
ANDERSON, C.C., MUKHERJEE, R., SINCLAIR, N.R.STC. & JEVNIKAR, respones in HIV-1 infection, 406
\.M. Hypogammaglobulinaemia occurs in FAS-deficient MRL-/pr mice "ARTRY, O., Moja, P., QUESNEL, A., PozzeTTo, B., LucHT, F.R. &
following deletion of MHC class II molecules, 473 GENIN, C. Quantification of IgA and IgG and specificities of antibodies
ANDERSON, C.J. see STAFFORD, H.A. to viral proteins in parotid saliva at different stages of HIV-1 infection,
A POSTOLOPOULOS, J. see HUANG, X.R. 47
ARAD, G. see GEREZ, lL Caspi, R.R. see THURAU, S.R.
ARATO, A. see SAVILAHTI, E CASSONE, A. see CARLESIMO, M.
ARMENGOL, P. see SOSPEDRA, M CATTANEO, R. see BRUGNONI, D
Asal, J. see KAWAGUCHI, Y CrupPENS, J.L. see VAN DEN Hove, L.E.
ASHHAB, Y. see SOSPEDRA, M. CHAN, C.-C. see THURAU, S.R.
AVRAMIDIS, N. see VICTORATOS, P CHAPEL, H.M. see MisBan, S.A
CHEN, A.E. see STAFFORD, H.A
BaArRT, L. see VAN DEN Hove, L.I Cuow, N.H. see Tsai, C.Y
BAKHIET, M. see DiaB A CLARK, M.A., Hawkins, N.J., PAPAIOANNOU, A., Fippes, RJ. &
BALK, S.P., see BLUMBERG, R.R WarbD, R.L. Isolation of human anti-c-erhB-2 Fabs from a lymph
BARINGTON, T. see JUUL, I node-derived phage display library, 166
BARRAT, F., LesouRD, B., BouLouts, H.-J.. THiBAULT, D., VINCENT- COLGAN, S.P., see BLUMBERG, R.R
NAULLEAU, S., GJATA, B., Loutses, A., NEwaAy, T. & PiLet, Cu. Sex COLLINS, F. see FALCONE, V.
and parity modulate cytokine production during murine ageing, 562 Coorevits, L. see VAN DEN Hove, L.E
BACK, O. see BENGTSSON, A. Coravo, J., Toro, F., Rivera, H., Blanco, N.E., Deipis, L. & Dt
BEERSMA, M.F.C. see TIMMERMANN, J.J. SANCTIS, J.B. Impairment of natural killer (NK) cytotoxic activity in
BEN-SMITH, A., GOODALL, J.C., Gaston, J.S.H. & Winer, J.B. Stimula- hepatitis C virus (HCV) infection, 451
tion of peripheral blood lymphocytes with Campylobacter jejuni gen- Crusius, J.B.A. see BouMA, G
erates a 76 T cell response in patients with Guillain-Barré syndrome,
121 D’souza, M. see HUANG, X.R
BENGTSSON, A., HOLM, L., BACK, O., FRANSSON, J. & SCHEYNIUS, A. Dana, M.R. see Sato, T.
Elevated serum levels of soluble cD30 in patients with atopic dermatitis Dana, M.R. see TIMMERMANN, J.J
(AD), 533 Dana, M.R. see VAN DIxHOooRN, M.G.A
BERNARDI, M.L. see CARLESIMO, M. DAHLGREN, C. see Liu, L
BIANCO, N.E. see CoRADO, J. DamiEN, B. see Huiss, S.
BISTONI, F. see MONARI, C. DaAMMACCO, F. see PEROSA, F.
BLUMBERG, R.R., COLGAN, S.P. & BALK S.P. CD1d: ouside-in antigen Dayer, J.-M. see KREUZER, K.-A.
presentation in the intestinal epithelium? 223 De Bruyn, J. see ZLoTTA, A.R.
Bocca, A.L. see SiLva, M.F. De LANDAzuRI, M.O. see MARAZUELA, M.
Bonay, M., ECHCHAKIR, H., Lecosster, D., Laing, P., HERMAN, D., De Rosa, F.G. see AFELTRA, A.
Hance, A.J., SOLER, P. & Tazi, A. Characterization of proliferative De Sanctis, J.B. see Corapo, J
responses and cytokine mRNA profiles induced by Vespula venom in De Souza, J.B. see Peet, N.M.
patients with severe reactions to wasp stings, 342 DEANE, K.H.O., Jecock, R.M., Pearce, J.H. & Gaston, J.S.H.
BONOMO, L. see AFELTRA, A. Identification and characterization of a DR4-restricted T cell epitope
BORGHETTI, A. see RONDA, N. within chlamydia heat shock protein 60, 439
BouLouls, H.-J. see BARRAT, F. Decock, M. see ZLoTTA, A.R.
BouMA, G., OUDKERK Poot, M., Crusius, J.B.A., SCHREUDER, Detsis, L. see CoRADO, J.
G.M.TuH., HELLEMANS, H.P.R., MEWER, B.U.G.A., KOSTENSE, P.J., De ves, P.J. see Pret, N.M.
GIPHART, M.J., MEUWISSEN, S.G.M. & PeNa, A.S. Evidence for Denis, O. see ZLOTTA, A.R.
genetic heterogeneity in inflammatory bowel disease (IBD); HLA DEWCHAND, H. see E.uiort, J.1.
genes in the predisposition to suffer from ulcerative colitis (UC) and Duinpbsa, M.S. see MEHROTRA, J.
Crohn’s disease (CD), 175 Dias, A., ZHU, J., Linpquist, L., WRETLIND, B., BAKHIET, M., & LINK,
Breic, M. see JUNGI, T.W. H. Haemophilus influenzae and Streptococcus pneumoniae induce
580 Author - Index
different intracerebral mRNA cytokine patterns during the course of GRAY, T. see MAHIDA, Y.R
experimental bacterial meningitis, 233 GRIFFITHS, H. see MISBAH, S.A
Discipio, R.G. see VAN DixHooRN, M.G.A GUERIN, J., FetGHery, C., Sim, R.B. & JACKSON, J. Antibodies to p2s92
DosBELAkgRE, D.A.E. see JUNGI, T.W glycoprotein | a specific marker for the antiphospholipid syndrome,
Donze, H.H., Lug, C., JULIAN, B.A., KUTTEH, W.H., KANTELE, A. & 304
MesTecky, J. Human peritoneal B-1 cells and the influence of contin- GUERRA, E.C. see CARLESIMO, M
uous ambulatory peritoneal dialysis on peritoneal and peripheral blood
mononuclear cell (PBMC) composition and immunoglobulin levels, 356 Hacsek, G. see SAVILAHTI, E
Dorn, M., Fricke, M., NICOLETTI, F., GAROTTA, G., VAN VELTHUYSEN, HADJIPETROU, L. see VICTORATOS, P
M.-L., BRUUN, J.A. & GLEICHMANN, E. Genetic differences in immune HAENEY, M.R. see MISBAH, S.A
reactivity to mercuric chloride (HgCl,): immunosuppression of H-2° HAMASAKI, N. see Cat, Y
mice is mediated by interferon-gamma (IFN-y), 149 Hance, A.J. see BONAY, M
DRAYTON, D. see Wu, Z.-Q HANEJI, N. see TAKAHASHI, M
DrowartT, A. see ZLOTTA, A.R HARLEY, J.B. see SCOFIELD, R.H
Duse, M. see BRUGNONI, D HASEGAWA, A. see KOMARI,S
HasHiImMoTo, H. see KANEKO, H
ECHCHAKIR, Ii. see BONAY, M HASHIMOTO, Y. see KASAI, K
ELGH, F. see ALEXEYEV, O.A HawkINs, N.J. see CLARK, M.A
ELGHAZALI, G., PERLMANN, H., Ruttra, A.S.M., PERLMANN, P. & HAYAKAWA, T. see IMADA, K
TROYE-BLOMBERG, M. Elevated plasma levels of IgE in Plasmodium HAYASHI, Y. see TAKAHASHI, M
falciparum-primed individuals reflect an increased ratio of IL-4 to HEEMSKERK,E . see SATO, T
interferon-gamma (IF N-y)-producing cells, 84 HELLEMANS, H.P.R. see BouMA, G
E.uiott, J.1., DeEwcHAND, H. & ALTMANN, D.M. Streptozotocin HERMAN, D. see BONAY, M
induced diabetes in mice lacking of af cells, 116 HIRSCHMANN, O. see GEREZ, |
ELWING, H. see Liv, | HISHIKAWA, T. see KANEKO, H
ENGEL, A.-M., SVANE, I.M., MADSEN, M.W., PEDERSEN, M. & WERDE- Ho, T.S. see Tsai, C.Y
LIN, O. Molecular aberrations in the MHC class I-restricted pathway for HOLDsworTH, S.R. see HUANG, X.R
antigen presentation in methylcholanthrene sarcomas from nude mice Hoi, K. see SAVILAHTI, I
discrepancies between MHC mRNA and surface protein, 323 Hom, L. see BENGTSSON, A
NOMOTO, A. see KAKUMU, S HomBuRGER, H.A. see SPECKS, lt
rOH, F. see Cal, Y Houas, L. see JuuL, |
HUANG, X.R., TippinGc, P.G., APOSTOLOPOULOS, J., OETTINGER, (¢
ACCHETTI, P. see GATTORNO, M D’souzA, M., MILTON, G. & HOLDSworRTH, S.R. Mechanisms of T
ALCONE. V. & COLLINS, F. Growth of recombinant Mycobacterium cell-induced glomerular injury in anti-glomerular basement membrane
tuberculosis H37Ra in mouse macrophages, 80 (GBM) glomerulonephritis in rats, 134
EIGHERY,C . see GUERIN, J Hutss, S., DAMIEN, B., SCHNEIDER, F. & MULLER, C.P. Characteristics of
ELLS, P. see PAPPA, A asymptomatic secondary immune responses to measles virus in late
ERRACINI, R., JR see SILVA, M.I convalescent donors, 416
ERRI, G.M. see AFELTRA, A HuyYGEN, K. see ZLOTTA, A.R
IDDES, R.J. see CLARK, M.A
IGUEIREDO, F. see SILVA, M.F IcHIMIYA, S. see KASAI, K
0Z-SALA, M. see SOSPEDRA, M IDA, K. see SHIRAI, R
RANSSON,J . see BENGTSSON, A IMADA, K., FUKUDA, Y., KOYAMA, Y., NAKANO, I., YAMADA, M..,
RANSSON, J. see VAN DER PLOEG, | KATANO, Y. & HAYAKAWA, T. Naive and memory T cell infiltrates in
REELAND, A. see MISBAH, S.A chronic hepatitis C: phenotypic changes with interferon treatment, 59
RICKE, M. see DotH, M IMriE, H.J. & Jones, D.R.E. Complement coating of erythrocytes is
RIEDRICH, B. see BUEHRING, | reduced following their interaction with neutrophils in vitro without
UJINO, M. see KAWAGUCHI,Y loss of complement receptor | (CR1), 217
UKUDA, Y. see IMADA,K INABA, Y. see ISHIGURO, A
UKUSHIMA, K. see ISHIGURO, A ISHIGURO, A., SUZUKI, Y., INABA, Y., FUKUSHIMA, K., KOMIYAMA, A..,
URGER, A. see JUNGI, T.W KOEFFLER, H.P. & SHimpo, T. The production of IL-8 in cerebrospinal
fluid in aseptic meningitis of children, 426
GALVIN, A.M. see MAHIDA, Y.R ISHIKAWA, T. see KAKUMU, S
GarortTa, G. see DoTH, M ISHIMARU, N. see TAKAHASHI, M
Gaston, J.S.H. see BEN-SmiTH, A IsouIMA, S. see KOMARI,S
Gaston, J.S.H. see DEANE, K.H.O Iro, M. see KAWAGUCHI, Y
GatTTI, R. see RONDA, N
GATTORNO, M., FACCHETTI, P., GHIOTTO, F., VIGNOLA, S., BUONCOM- JACKSON, J. see GUERIN, J
PAGNI, A., PRIGIONE, I., Picco, P. & Pistoia, V. Synovial fluid T cell JARAQUEMADA, D. see SOSPEDRA, M
clones from oligoarticular juvenile arthritis patients display a prevalent Jecock, R.M. see DEANE. K.H.O
rh1/ThO-type pattern of cytokine secretion irrespective of immunophe JEDDI TEHRANI, M. see VAN DER PLOEG, |
notype, 4 JENNE, L., KILWINSKI, J., SCHEFFOLD, W. & KERN, P. IL-5 expressed by
GaAwkKropcer, D.J. see Kemp, E.H CD4 lymphocytes from Echinococcus multilocularis-infected
GENIN, C. see CARTRY, O patients, 90
GeREZ, L., SHKOLNIK, T., HIRSCHMANN, O., LorBER, M., ARAD, G. & JEVNIKAR, A.M. see ANDERSON, C.(
KAEMPFER, R. Hyperinducible expression of the interferon-gamma Jones, D.R.E. see ImMrig, H.J
(IFN-y) gene and its suppression in systemic lupus erythematosus JONGEN, P. see RuTJES, S.A
(SLE), 296 JULIAN, B.A. see Donze, H.H
GHIOoTTO, F. see GATTORNO, M JUNGI, T.W., Brcic, M., SAGER, H., DOBBELAERE, D.A.E., FURGER, A.
GIPHART, M.J. see BouMA, G & Ropiti, I. Antagonistic effects of IL-4 and interferon-gamma (IFN-y)
GJATA, B. see BARRAT, I on inducible nitric oxide synthase expression in bovine macrophages
GLEICHMANN, E. see DotH, M exposed to Gram-positive bacteria, 431
GOooDALL, J.C. see BEN-SMITH, A JURION, F. see ZLOTTA, A.R
Goopricu, J.M. see Li, C JutTo, P. see ALEXEYEV, O.A
Author * Index 581
JuuUL,L ., HouGs, L., ANDERSEN, V., SVEJGAARD, A. & BARINGTON, T Li,C ., Goopricn, J.M. & YANG, X. Interferon-gamma (IFN-y) regulates
‘he normally expressed « immunoglobulin light chain gene repertoire production of IL-10 and IL-12 in human herpesvirus-6 (HHV-6)-infected
and somatic mutations studied by single-sided specific polymerase chain monocyte/macrophage lineage, 421
reaction (PCR); frequent occurrence of features often assigned to auto- IGHTMAN, S. see Pappa, A
immunity, 194 AINDERHOLM, M See ALEXEYEV, O.A
INDQUIST, | See DiaB A
Kapbota, J. see SHIRAI, R INK, H. see DiaB A
KAEMPFER, R. see GEREZ, I ru, L., ELwina, H.., KARLSSON, A., Nimeri, G. & DAHLGREN, (¢
KAJITANI, H S€€ TOMIOKA,H Surface-related triggering of the neutrophil respiratory burst. Character
KAKUMU, S., OKUMURA, A., ISHIKAWA, T., YANO, M., ENomorTo, A.., ization of the response induced by IgG adsorbed to hydrophilic and
NISHIMURA, H., YOSHIOKA, K. & YOSHIKAI, Y. Serum levels of IL-10, hydrophobic glass surfaces, 204
IL-15 and soluble tumour necrosis factor-alpha (TNF-a) receptors in LorBer, M. see GEREZ, |
type C chronic liver disease, 458 Louises, A SCE BARRAT,I
KAMEDA, K S€¢ KOMARI,S LouTrari, H., KoKLA, A., TRAKAS, N. & Tzarrtos, S.J. Expression of
KANEKO, H., HISHIKAWA, T., SEKIGAWA, I., HASHIMOTO, H., OKUMURA, human- Torpedo hybrid acetylcholine receptor (AChR) for analysing
K. & KANEKO, Y. Role of tumour necrosis factor-alpha (TNF-a) in the the subunit specificity of antibodies in sera from patients with
induction of HIV-1 gp120-mediated CD4 T cell anergy, 41 myasthenia gravis (MG), 538
KANEKO, S See Y AMASHITA,N CAS-MarTIN, A. see SOSPEDRA, M
KANEKO, S., SUZUKI, N., Korzumi, H., YAMAMOTO, S & SAKANE, CCARELLI, G S€e PEROSA,F
Rescue by cytokines of apoptotic cell death induced by II a deprivation CHT, F.R S€€ CarRTRY,O
of human antigen-specific T cell clones, 185 DGATE, M see PAPPA, A
KANEKO, Y See KANEKO,H E, ¢ SEE Donze, H.H
KANTELE, A See Donze, H.H ND, I See PEET, N.M
KARLSSON, A. see Liv, I
KASAI, K., MATSUURA, A., KIKUCHI, K., HASHIMOTO, Y & ICHIMIYA,S Mapsen, M.W see ENGEL, A.-M
Localization of rat CDI transcripptt s and protein in rat tissues—an Mauipa, Y.R., GALVIN, A.M., GRay, T., MAKHA, S., MCALINDON,
analysis of rat CD1 expression by in situ hybridization and immuno- M.E., SEWELL, H.F. & Popotsky, D.K. Migration of human intestinal
histochemistry, 317 lamina propria lymphocytes, macrophages and eosinophils following the
KATANO, Y See IMADA,K loss of surface epithelial cells, 377
KAWAGUCHI, Y., OKADA, T., KONISHI, H., FusINo, M., Asal, J. & ITo, MAKHA, S. see MAHIDA, Y.R
M. Reduction of the DTH response is related to morphological changes MALACARNE, F. see BRUGNONI, D
of Langerhans cells in mice exposed to acute immobilization stress, 397 MARAZUELA, M., DE LANDAzURI, M.O., LARRANAGA, E. & SANCHEZ-
KAWAKAMI, K. see SHIRAI, R MADRID, F. Up-regulated £8 -integrin expression in autoimmune thyroid
Kemp, E.H., GAWKRODGER, D.J.., WATSON P.F. & WEETMAN, A.P disorders, 107
Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo MATSUURA, A. see KASAI, K
sera: evidence for cross-reactive autoantibodies to tyrosinase and MATUSEVICIENE, G SCE VAN Der PLOgG, |
tyrosinase-related protien-2 (TRP-2), 495 MAZZONE, A.M S€e CARLESIMO, M
KERN, P. see JENNE, | MAKI, M. see SAVILAHTI, E.
KIKUCHI, K See KASAI,K McALINDON, M.f S€¢€ MAHIDA, Y R
KILWINSKI, J. see JENNE, L. McKEATING, J.A See PEET, N.M
KINOSHITA, S. see CAI, Y MEenurROTRA, J., MITTAL, A., DHINDSA, M.S. & SINHA, S. Fractionation of
KITAJIMA, S. see Cal, Y mycobacterial integral membrane proteins by continuous elution SDS-
KLEMOLA, T. see SAVILAHTI, I PAGE reveals the immunodominance of low molecular weight subunits
KLONISCH, T. see PEET, N.M for human Tc ells, 446
KOEFFLER, H.P S€€ ISHIGURO, A MEWER, B.U.G.A. see BOUMA, G
KOHNO, S. see SHIRAI, R MestTeECKY, J. see DoNzE, H.H
Korpe, J. see TAKEUCHI, T MEUWISSEN, S.G.M S€€ Bouma, G
KoizuMI, H Se KANEKO,S MILTON, G See HUANG, X.R
KOKLA, A See LOUTRARI, H. MisBaH, S.A., GRIFFITHS, H., MITCHELL, l., FREELAND, A., HAENEY,
KOMARI, S., KAMEDA, K., SAKATA, K., HASEGAWA, A., Tost, H., Tsui, M.R. & CHAPEL, H.M Antipolysaccharide antibodies in 450 children
Y., SHIBAHARA, H., KOYAMA, K. & Isojyrma, S. Characterization of with otitis media, 67
fertilization-blocking monoclonal antibody 1G12 with human sperm- MITCHELL, T S€€ MisBaAH, S.A
immobilizing activity, 547 MITTAL, A. see MEHROTRA, J
KOMIYAMA, A SCE IsHIGURO, A MIZUSHIMA, Y See Y AMASHITA, N
KONISHI, H. see KAWAGUCHI, ¥ Moga, P. see CARTRY,O
KOSTENSE, P.J S€e Bouma, G MonarI, C., RETINI, C., PALAZZETTI, B., BISTONI, I & VECCHIARELLI,
KOYAMA, K. see KOMARI, S. A Regulatory role of exogenous Il 10 in the development of immune
KOYAMA, Y See IMADA, K response versus Cryptococcus neoformans, 242
KREMMER, E., MySLiwiktZ, J. & THIERFELDER, S. Induction and suppres MulZert,Y . see VAN DixHoorRn, M.G.A
sion of anti-antibodies to syngeneic T cell-binding antibodies in mice, MUKHERJEE, R S€€ ANDERSON, C.(
180 MULLER, C.P. sSe¢ e Huss,S
KREUZER, K.-A., DAYER, J.-M., ROCKSTROH, J.K., SAUERBRUCH, T & MuscartT, F. see ZLoTTAA,. R
SPENGLER, | The IL-1 system in HIV infection: peripheral concentra MYSLIWIETZ, J. see KREMMER, I
tions of IL-18, IL-1 receptor antagonist and soluble IL-1 receptor type II
54 NAKANO, | S€¢ IMADA, K
KURIEN, B.T. see SCOFIELD, R.H Natori, YA. see NATORI, Yt
KUTTEH, W.H. see Donze, H.H Natori, YU., SEKIGUCHI, M., Ou, Z. & NATORI, YA. Gene expressioonf
CC chemokines in experimental crescentic glomerulonephritis (CGN),
LAINE, P S€E Bonay, M 143
LARRANAGA, I S€eé MARAZUELA, M. Neas, B.R. see STAFFORD, H.A
LecossiER, D. see BONAY, M NeMETH, A. see SAVILAHTI, F
Lee, L.A. see STAFFORD, H.A. Neway, T. see BARRAT, fF
Let, H.Y. see Tsai, C.Y NICOLETTI, F. see DotH, M
LESOURD, B. see BARRAT, I NIMERI, G See Liu, L.
582 Author Index
NISHIMURA, H. see KAKUMU, S enhances antibody-mediated apoptosis of cultured rat glomerular mesan-
NUSSENBLATT, R.B. see THURAU, S.R. gial cells, 510
SAUERBRUCH, T. see KREUZER, K.-A
OBETTINGER, C. see HUANG, X.R SAVILAHTI, E., ORMALA, T., ARATO, A., Hacsek, G., Hoim, K..,
OGAWA, K. see SHIRAI, R KLEMOLA, T., NEMETH, A., MAKI, M. & REUNALA, T. Density of
OKADA, T. see KAWAGUCHI, Y y/5* cells in the jejunal epithelium of patients with coeliac disease and
Oxuso, K. see Cal, Y dermatitis herpetiformis is increased with age, 464
OKUMURA, A. see KAKUMU, S. SANCHEZ-MADRID, F. see MARAZUELA, M
OKUMURA, K. see KANEKO, H SCHAAF, J. see BUEHRING, |
ORLANDINI, G. see RONDA, N SCHEFFOLD, W. see JENNE, L.
Ou, Z. see NATORI, Yt ScCHEYNIUS, A. see BENGTSSON, A
OUDKERK POOL, M. see BOUMA, G SCHEYNIUS, A. see VAN DER PLOEG, I
OrRMALA, T. see SAVILAHTI, E SCHMIDT, H. see BUEHRING, I
SCHNEIDER, F. see Hutss, S
PAGANELLI, R. see CARLESIMO, M SCHREUDER, G.M.TH. see BOUMA, G
PALAZZETTI, B. see MONARI, ¢ SCHULMAN, C.C. see ZLOTTA, A.R
PALFLIET, K. see ZLOTTA, A.R SCOFIELD, R.H., ZHANG, F.-C., KURIEN, B.T. & HARLEY, J.B. Anti-Ro
PANG, M. see TAKEUCHI, T fine specificity defined by multiple antigenic peptides identifies compo-
PAPAIOANNOU, A. see CLARK, M.A nents of tertiary epitopes, 480
Pappa, A., CALDER, V., AJJAN, R., FELLS, P., LUDGATE, M., WEETMAN, SEKIGAWA, I. see KANEKO, H
\.P. & LIGHTMAN, S. Analysiosf extraocular muscle-infiltrating T cells SEKIGUCHI, M. see NAToRI, Yt
in thyroid-associated ophthalmopathy (TAO), 362 SEWELL, H.F. see MAHIDA, Y.R
PauL, A.G.A. see STAFFORD, H.A SHEKARSARAI, H. see ZLOTTA, A.R
Pearce, J.H. see DEANE, K.H.O SHIBAHARA, H. see KOMARI, S
PEDERSEN, M. see ENGEL, A.-M SHIMBO, T. see ISHIGURO, A
Peet, N.M., MCKEatTING, J.A., RAMos, B., KLONISCH, T., DE Souza, SHIMIZU, T. see ToMIOoKA, H
J.B., Detves, P.J. & LuNb, T. Comparison of nucleic acid and SuHiral, R., Kapora, J., TomMONO, T., OGAWA, K., IDA, K.,. KAWAKAMI,
protein immunization for induction of antibodies specific for HIV-1 gp K. & KOHNO, S. Protective effect of granulocyte colony-stimulating
120, 226 factor (G-CSF) in a granulocytopenic mouse model of Pseudomonas
Pena, A.S. see BoUMA, G aeruginosa lung infection through enhanced phagocytosis and killing
PERLMANN, H. see ELGAHAZALI, G. by alveolar macrophages through priming tumour necrosis factor-
PERLMANN, P. see ELGAHAZALI, G alpha (TNF-a) production, 73
Perosa, F., LUCCARELLI, G. & DAMMACCO, F. Absence of streptococcal SHKOLNIK, T. see GEREZ, i
protein G (PG)-specific determinant in the Fab region of human IgG2, Sitva, C.L. see Si-va, M.I
79 Sitva, M.F., Bocca, A.L., FERRACINI, R., JR, FIGUEIREDO, F. & SILVA,
Picco, P. see GATTORNO, M C.L. Cellular requirements for immunomodulatory effects caused by cell
PiteT, Cu. see BARRAT, I wall components of Paracoccidioides brasiliensis on antibody produc-
Pirson, M. see ZLOTTA, A.R tion, 261
PiseTsKY, D.S. see Wu, Z.-Q Sim, R.B. see GUERIN, J
Pistoia, V. see GATTORNO, M Simon, J. see ZLOTTA, A.R
Popo.Lsky, D.K. see MAHIDA, Y.R SINCLAIR, N.R.STC. see ANDERSON, C.¢
PONTESILLI, O. see CARLESIMO, M SINHA, S. see MEHROTRA, J
PozzeTTo, B. see CARTRY, O SMULIAN, A.G. see THEUS, S.A
PRIGIONE, I. see GATTORNO, M. SOLER, P. see BONAY, M
PRUUN, G.J.M. see Rutyes, S.A SOsPEDRA, M., ToLosa, I ARMENGOL, P., ASHHAB, Y., URLINGER, S.,
PUJOL-BORRELL, R. see SOSPEDRA, M LucAS-MartTIN, A.., Foz-SaLa, M., JARAQUEMADA, D. & PUJOL-
BORRELL, R. Hyperexpression of transporter in antigen processing-|]
QUESNEL, A. see CARTRY, O (TAP-1) in thyroid glands affected by autoimmunity: a contributory
factor to the breach of tolerance to thyroid antigens? 98
RAMos, B. see PeeT, N.M Specks, U., WigGERT, E.M., & HomMBuRGER, H.A. Human mast cells
RetTINI,C . see MONAaRI, ¢ expressing recombinant proteinase 3 (PR3) as substrate for clinical
REUNALA, T. see SAVILAHTI, I testing for anti-neutrophil cytoplasmic antibodies (ANCA), 286
RIveRA, H. see Corapo, J SPENGLER, U. see KREUZER, K.-A
ROCKSTROH, J.K. see KREUZER, K.-A STAFFORD, H.A., CHEN, A.E., ANDERSON, C.J., PAUL, A.G.A., WYATT,
Ropiti, I. see JUNG1, T.W E.L., Lez, L.A. & Neas, B.R. Anti-ribosomal and *P-peptide’-specific
RONDA, N., Gatti, R., ORLANDINI, G. & BORGHETTI, A. Binding and autoantibodies bind to T lymphocytes, 12
internalization of human IgG by living cultured endothelial cells, 211 SULLIVAN, D.W. see THeEus, S.A
Rosso, R. see CARLESIMO, M SUZUKI, N. see KANEKO, S
Rutyes, S.A., VREE EGBERTS, W.T.M., JONGEN, P., VAN DEN HOOGEN, SuzuKI, Y. see ISHIGURO, A
F., Pruun, G.J.M. & VAN VeNROOU, W.J. Anti-Ro52 antibodies SVANE, I.M. see ENGEL, A.-M
frequently co-occur with anti-Jo-1 antibodies in sera from patients with SVEJGAARD, A. see JUUL, |
idiopathic inflammatory myopathy, 32
Rutta, A.S.M. see ELGAHAZALI, G TAKAHASHI, M., ISHIMARU, N., YANAGI, K., HANEJI, N., Sarto, L. &
HAYASHI, Y. High incidence of autoimmune dacryoadenitis in male non-
SAGER, H. see JUNGI, T.W obese diabetic (NOD) mice depending on sex steroid, 555
Saito,H . see Tomioka,H TAKENO, M. see YAMASHITA, N
SatTo, |. see TAKAHASHI, M TAKEUCHI, T., PANG, M., AMANO, K., Kobe, J. & ABE, T. Reduced protein
SAKANE, T. see KANEKO, S tyrosine phosphatase (PTPase) activity of CD45 on peripheral blood
SAKANE, T. see YAMASHITA, N lymphocytes in patients with systemic lupus erythematosus (SLE), 20
SAKATA, K. see KOMARI, S Tazi, A. see BoNAY, M
SANO,C . see TOMIOKA, H TARNVIK, A. see ALEXEYEV, O.A
SATO, K. see Tomioka,H THeus, S.A., SMULIAN, A.G., SULLIVAN, D.W., & WaALzerR, P.D
Sato, T., VAN DixHooRN, M.G.A., HEEMSKERK, E., VAN Es, L.A. & Cytokine responses to the native and recombinant forms of the major
Dana, M.R. Clq, a subunit of the first component of complement, surface glycoprotein of Pneumocystis carinii, 255
Author - Index
THIBAULT D. see BARRAT,I VAN VoorEN, J.P see ZLOTTA, A.R
THIERFELDER, S see KREMMER, f VARANI, A.R see CARLESIMO, M
PHURAU, S.R CHAN, C.-C., NUSSENBLATT, R.B. & ( ASPI R.R. Oral VECCHIARELLI, A S€€ Monarl, ¢
tolerance in 1 murine model of relapsing experimental autoimmune VENABLES, P.I W. Antibodietso Jo-1 and Ro
uveoretinitis (EAU): inductioonf prottolereancce int priimedv aneimal s, 403
0 VERWEL, ¢ See VAN DixHoorN, M.G \
TIMMERMAN, J.J See VAN DIXHOORN, M.G \ ViICTORATOS, P.., YIANGOU, M., Av RAMIDIS DJIPETROL
TIMMERMAN, J.J.. BEERSMA, M.F.C., VAN GULSWUK-JANSSEN, D.J.. VAN Regulation of cytokine gene expression by adj 69
Es, L.A., VAN Der Woupe, F.J. & DAHA, M.R. Differential effects of VIGNOLA, S SEC GATTORNO, M
cytomegalovirus infection on complement synthesis by human mesan VINCENT-NAULLEAU, S. see BARRAT, I
gial cells, 518 VREE EGperts, W.T.M. see RUTJES he)
TiMPANO, S. see BRUGNONI, D
TIPPING, P.G See Ht ANG X.R WADELL, P. see ALEXEYEV, O.A
Ton, H Sée KOMARI S WAHLGREN,C .]I See VAN Der PLOEG,|
To.osa,E . see SOSPEDRA M WALCHNER, M. & Wick, M Elevation of CD8* CDI Ib
TOMIOKA, H SATO K., SANO, C., AKAKI,T ., SHimizu, T., KAJITANI,H is associated with the humoral immunodeficiency in m
& SAITO H Effector molecules of the host defence mechanism against 310
VM cobacterium avium complex: the evidence showing that reactive WaALZER, P.D see THEUS, S.A
oxygen Il mediates, reactive nitrogen intermediates, and free fatty Warp, R.1 S€e€ CLARK, M.A
acids each alone are not decisive in expression of macrophage Watson, P.I See Kemp, E.H
antim icrot ial activity against the parasites, 248 WEETMAN, A.P See Kemp, E.H
TOMONO, T see SHIRAI, R WEETMAN, A.P Se¢ Pappa, A
Toro, I S€e Corapo, J WERDELIN,O See ENGEL, A.-M
TRAKAS, N. see | OUTRARI, H Wick, M See WALCHNER, M
TROYE-BLOMBERG, M. see ELGAHAZALI, G WIEGERT, I M see SPECKS, |
[Sal 7% HOW N.H., Ho, T.& SLet., H .Y Intracerebral injection of WINER, J.B. see BEN-SMiITH, A
myelin basic protein (MBP) induces inflammation in brain and causes WINFIELD, J.B. Are anti-ribosomal P protein antibodies a type
paraplegia in MBP-sensitized B6 mice, 12 lymphocyte antibody?, |
Tsust, ¥ See KOMARI, S WRETLIND, B SCE DiaB A
TZArTOS, S.J. see Lot rR ARI, H Wu, Z.-Q., DRAyY1 N, D. & Pisetsky, D.S. Specificity and Immuno
chemical properties of antibodies to bacterial DNA in sera of normal
UGAZIO, A.G see BRUGNONI D human subjects and patients with systemic lupus erythematosus (SLI
URLINGER, S. see SOSPEDRA M —
Wyatt, E.L. see STAFFORD, H.A
AN DAMMES, B See VAN DEN Hove, L.f
AN DEN HOoGeNn, F. see RuTJES, S.A AMADA, M S€e IMADA, K
AN Den Hove, L.E.. VAN Goo, S.W , VAN POPPEL H., BAeRT, | AMAMOTO S. see KANEKO, S
Coorevits, | VAN DAMMES, B & CEUPPENS I] Phenotype, AMASHITA, N.., TAKENO, M KANEKO, S., MIZUSHIMA, Y. & SAKANI
cytokine production ind cytolytic capacity of fresh (uncultured) I. Therapeutic effectso f preferential induction of mite-specific T helper
tumour-infiltrating T lymphocytes in human renal cell carcinoma, 501 0 clones, 332
AN Der PLOEG, |., JEDDI TEHRANI, M., MATUSEVICIENI G WAHLG YANAGI, K. si TAKAHASHI. M
REN C.F., FRANsSSON, J. & ScHEYNiUS, A. IL-13 over-expression in Y ANG X See Li,¢
skin is not confined to IgE-mediated skin inflammation 526 Y ANO M. see KAKUMU, S
VAN Der Woupe, F.J. see TIMMERMANN, J.J YIANGOU, M see VICTORATOS e
AN DIXHOORN, M.G.A. see SATO, T YOSHIKAI,Y See KAKUMU, ‘5
VAN DIxHooRN, M.G.A., TIMMERMAN, J.J.. VAN GULSWIK-JANSSEN, YOSHIOKA, K see KAKUMU, S
D.J.. MUIZERT, Y., VERWEL, ¢ Discipio, R.G. & Dana, M.R
Characterization of complement C6 deficiency in a PVG/c rat Strain 387 ZHANG, I -( see SCOFIELD R.H
AN Es, L.A S€€ SATO, T ZHV, J S@e DiaB A
AN Es, | \ Sé¢ TIMMERMANN, J.J ZIELEN S see BUEHRING, |
AN GULSWUK JANSSEN D.J See TIMMERMANN, J.J ZLoTTA, A.R., DROWART A... HUYGEN K.. De Bruy» SHEKAR
AN GULSWUK-JANSSEN, D.J see VAN DIXHOORN, M.G.A SARAI, H., DEcocK, M PiRSON, M JURION, F., PALFLIET, K., DENIS,
AN GOOI S.W. see VAN DEN Hove, L.f O., Muscart, I Simon, J SCHULMAN C.C. & VAN Vooren, J.P
AN POPPE H Ya: VAN Den Hove, L. Humoral response against heat shock proteins and other mycobacterial
AN VEI rHUYSEN, M.-I Se¢ Dotu, M antige! 1s after intravesical treatment w ith bacille Calmette-Guerin (BCG)
«<<y<aaaani < A N VENROOL W.J See RuTtyes, S.A in patients with superficial bladder cancer, 15
Subject Index
icc -tyicholine comple| ment . C6 d’ eficiency, 38
idjuvant, 569 continuous ambulatory peritoneal dialysis, 356
ige, 464 continuous elution SDS-PAGE, 446
ageing 562 ostimulation, 406
AIDS, 226, 255 R1, 217
illergy, 342 rescentic
AN( A 286 rohn’s disease
anti-antibodies, 180 rvp}r
anti-DNA ar dies tokine, y dodaly
anti-GBM a od ytokine mRNA, 342
inti-iym ytokine secretion, 50]
98. 362. 468
yu inalysis, 2/9
intibodie nphocytes
ntibody toxicity, 45]
1lospholipid
ipOptosis 185
issocialion Netel!
isthma
itopic dermatiti
1utoantibody
iutoantibody
iloantigen
it
1utoimmune
iutoimmun!
fatty acids, 248
glycoprote free radical release, 204
B lymphocyt
B-1 cells, 35¢
bacterial DNA *ment, 194
Dasement memodI glomerulonephritis, 134, 38
BCG vaccin 1120, 41
2p 160 406
yranuiocyte Cc ny-sumulating
granulocytes, 279
granulocytopenic mice, 73
Graves’ disease, 107
grommets (ear tubes), 67
irdiolinin Guillain-Barre syndrome, 121
attle, 431
D23, 351 H,O,-mediated halogenation system, 248
D28° T Haemophilus influenzae, 233
D4, 134 haemorrhagic fever with renal syndrome, 35
D45RA hantavirus, 351
D45RO. § heat shock proteins, 157
D8, 134 hepatitis C virus, 451
HIV gp120 IIIB, 226
HIV infection, 54
HIV’ children, 412
C HIV-1, 41, 47, 406
HLA, 98, 175
( homing recept
chemokine, | hsp60, 439
children, 426 human, 166
chronic hepat human alveolar echinococcosis, 90
chronic relapsing auton human antigen-specific T cell clone, 185
chronic sinusitis, 468 human cytomegalovirus, 518
coeliac disease, 464 human herpesvirus-6, 421
competitive RT-PCR human IgG, 272
complement, 217, 510 S18 human T cell proliferation, 446
Subject Index
myasthenia gravis, 538
mycobacteria, 157
Mycobacterium, 446
Mycobacterium avium complex 248
Mycobacterium fortuitum, 446
Mycobacterium tuberculosis, 80
myeloma, 310
24
MYOSIUS, 32
6
NADPH-oxidase, 204
receptor antagonist, 54 natural killer cells, 451
4 21, 458 neutrophil, 217
.4 21 neutrophils, 204, 426
NO, 431
NOD mice, 116, 555
nude mice, 323
oral tolerance, 370
IL-8, 426 otitis media, 6
immunodeficiency
‘
immunofluorescence, 286 idioides brasiliensis, 261
immunoglobulin regulation, 310 yarotid saliva, 47
immunoglobulin subclasses, 416 yeptides, 480
immunoglobulin variable region genetics, 194 yeritoneal lymphocytes, 356
yumunohistochemistry, 317 vhage display, 166
immunology, 107 yneumonia, +>
immunosuppression r0lyclonal, 310
n situ hybridization, poly saccharide antibodies, 6
inducible nitric oxide oregnancy, 56 )
infection, 451 proliferation, 406
nfiltrating lymphocyte, 59 rotein adsorption, 204
inflammation yroteinase 3, 286
/ » SCUGdj OIMM, ONASJ ij vi , vl
nediators, 468 psoriasis, 533
> proteins, 446 psychoneuroin
Puumala virus, 351
interferon-gamma, 84, 149, 296
interferons, 518
intestine, 377 ular Mesange
intracerebral stimulation, 127 arthritis, 439
isotype switching, 569 nitrogen intermediates, 248
eactive oxygen intermediates, 248
renal cell carcinoma, 501
juvenile arthritis, 4 ribosomal proteins, 12
Ro ribonucleoprotein complex, 32
kidney, 518 Ro (SS-A), 32
RT-PCR, 342
lacrimal gland, 555
lactoferrin, 279 seborrhoeic dermatitis, 533
lupus, 473 secondary immune response, 416
lymphocyte subsets, 501 serum level, 458
lymphocytes, 3
lymphokine-activated killer cells, 451] sex steroid, 555
signal transduction, 20
macrophage, 73, 134, 248 Sjégren’s syndrome, 555
macrophage subpopulations, 261 skin, 397, 526
macrophages, 80, 377, 431 soluble CD30, 533
MCA, 323 soluble IL-1 receptors, 54
measles, 416 sperm immobilization, 547
meningitis, 233, 426 STAT, 185
mercuric chloride, 149 Streptococcus, 233
mesangial cells, 518 streptococcus protein G, 272
MHC class I, 323 streptozotocin, 116
mice, 562 stress, 397
monoclonal, 310 suppression, 296
monoclonal and polyclonal antilactoferrin antibodies, surface interaction, 204
monoclonal antibody, 547 syngeneic anti-T cell MoAb, 180
monocytes, 242 systemic lupus erythematosus, 12, 27, 296, 480
MRI scan, 468
mRNA, 296, 323, 362 cell, 134
mucosal immunity, 47 cell anergy, 41
mucosal immunology, 356 cell clone, 439
mutation, 194 cell clones, 4
586 Subject Index
I cell help, 473 tolerance, 473
T cell proliferation, 121 transcription factor TFIIF, 488
I cell receptor a//3, 464 transplantation, 180
T cell receptor 7/6, 464 transporter associated with antigen processing-1, 98
T cell receptor, 20 tumour necrosis factor-alpha, 73
I cell response, 90 tumour-infiltrating lymphocytes, 501
I cells, 116, 310, 526 tumours, 323
I lymphocyte, 406 typeC liver disease, 458
I lymphocytes, 362 tyrosinase, 495
test immunization, 67 tyrosinase-related protein-2, 495
Thi, 4, 332 tyrosine kinase, 20
Th! and Th2 balance, 84 tyrosine phophorylation, 20
Thi cells, 149
Th2, 332 ulcerative colitis, 175
Th2 cells, 149
Th2 cytokines, 90 vaccine, 226, 569
thrombosis, 304 vasculitis, 211
Thy-1, 510 virulence, 80
thyroid autoimmunity, 98 vitiligo, 495
thyroid-associated ophthalmopathy, 362
INF-a, 41 wasp venom, 342
TNF-a receptol 458 Wegener's granulomatosis, 2